P167: CD34 expression can predict a higher risk of development of Hepatocellular carcinoma in the setting of chronic Hepatitis C‐related cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|102-102

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 102-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Sustained Low Alanine Aminotransferase Levels Can Predict the Survival for 10 Years without Hepatocellular Carcinoma Development in Patients with Hepatitis C Virus-Associated Liver Cirrhosis of Child Stage A

By  

Intervirology, Vol. 47, Iss. 2, 2004-06 ,pp. : 65-71

Karger

Access to resources Recommend Favorite

Slight elevation of high‐sensitivity C‐reactive protein to predict recurrence and survival in patients with early stage hepatitis C‐related hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 645-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years

By  

Intervirology, Vol. 58, Iss. 1, 2015-01 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Comparison of improved prognosis between hepatitis B‐ and hepatitis C‐related hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E99-E107

John Wiley & Sons Inc

Access to resources Recommend Favorite